Stiftung Institut fuer Herzinfarktforschung

Academic/HospitalWebsite ↗

Also known as: Stiftung Institut fÃ¼r Herzinfarktforschung | Stiftung Institut fuer Herzinfarktforschung | Stiftung Institut fuer Herzinfarktforschung, Chairman

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Oct 1, 2003

Last known activity

Feb 28, 2018

Timeline

No events for the selected filters.

Drugs by trial phase (10 distinct, 4 trials)

Phase 4 (8 own, 0 via acquisition)

edoxaban
dabigatran
warfarin
acetylsalicylic acid
phenprocoumon
rivaroxaban
apixaban
clopidogrel

Phase 3 (2 own, 0 via acquisition)

icosapent ethyl
prasugrel

Indications

Studied for

Atrial Fibrillation
Death
Death, Sudden, Cardiac
Infarction
Myocardial Infarction

Recent trials (5)

NCT03463317CollaboratorPhase 4Feb 28, 2018
NCT01327534Lead sponsorPhase 3May 1, 2011
NCT00372216Lead sponsorPhase 3Oct 1, 2006
NCT00251134Overall official - principal investigatorPhase 3Oct 1, 2003
NCT00251134Lead sponsorPhase 3Oct 1, 2003

Details

Founded: Ludwigshafen, DE
Last known activity: Feb 28, 2018